Picture of Koninklijke Philips NV logo

PHIA Koninklijke Philips NV Share Price

0.000.00%
nl flag iconLast trade - 00:00
HealthcareAdventurousLarge CapMomentum Trap

Momentum

Relative Strength (%)
1m-15.62%
3m-10.41%
6m-2.71%
1yr+12.29%
Volume Change (%)
10d/3m+59.38%
Price vs... (%)
52w High-18.83%
50d MA-12.41%
200d MA+3.09%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)15.31
PEG Ratio (f)1.21
EPS Growth (f)14.45%
Dividend Yield (f)3.59%
Valuation (ttm)IndustryMarket
Price to Book Value1.93
Price to Tang. Bookn/a
Price to Free Cashflow20.15
Price to Sales1.27
EV to EBITDA19.28

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital1.7%
Return on Equity-3.91%
Operating Margin1.96%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue€m17,14717,31317,15617,82718,16918,311.619,100.950.05%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-10.08+18.29+10.21-87.31+372.52+28.96+12.33n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Koninklijke Philips NV EPS forecast chart

Profile Summary

Koninklijke Philips NV is the Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care & Health Informatics businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The HealthTech Other segment comprises such items, as innovation, emerging businesses, royalties, among others. The Legacy Items segment consists mainly of separation costs, legacy legal items, legacy pension costs, among others.

Directors

Last Annual
December 31st, 2023
Last Interim
September 30th, 2024
Incorporated
November 14th, 2000
Public Since
September 18th, 2009
No. of Shareholders
820
No. of Employees
69,282
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
nl flag iconEuronext - Amsterdam
Shares in Issue
934,117,064

PHIA Share Price Performance

Upcoming Events for PHIA

Q4 2024 Koninklijke Philips NV Earnings Release

Q1 2025 Koninklijke Philips NV Earnings Release

FAQ